Close

Pharmaceutical Leader | Gao Yansong, General Manager of Jiuzhitang Maker: Patiently Cultivating "Good Cells" for the Vast Horizons of Regenerative Medicine

China Securities Journal Exclusive Interview | Dr. Gao Yansong of Jiuzhitang Maker: Decoding the "Seeds of Life"—Stem Cells
Close

China Securities Journal Exclusive Interview | Dr. Gao Yansong of Jiuzhitang Maker: Decoding the "Seeds of Life"—Stem Cells

"China Securities Journal" Focuses on Jiuzhitang Maker: Stem Cells Shine a Light on "Children of the Stars"
Close

"China Securities Journal" Focuses on Jiuzhitang Maker: Stem Cells Shine a Light on "Children of the Stars"

The Value and Future of "Good" Stem Cells
Close

The Value and Future of "Good" Stem Cells

"The 'Good' Path to Turning Stem Cells into Medicines"
Close

"The 'Good' Path to Turning Stem Cells into Medicines"

"How 'good' stem cells are generated
Close

"How 'good' stem cells are generated

The criteria for "good" stem cells
Close

The criteria for "good" stem cells

Jiuzhitang Maker's Phase IIa Clinical Trial for Stem Cell Therapy in Rare Lung Diseases Officially Launches
Close

Jiuzhitang Maker's Phase IIa Clinical Trial for Stem Cell Therapy in Rare Lung Diseases Officially Launches

Jiuzhitang Invests in Building a Stem Cell Production Base
Close

Jiuzhitang Invests in Building a Stem Cell Production Base